Preferences of diabetes patients and physicians: A feasibility study to identify the key indicators for appraisal of health care values

Table 2 Factor and factor levels as ranked by patients.

Factors	Factor levels	Weights of factor levels
		All patients	Normal body weight	Mild over-weight	Adipositas I	Adipositas II+III
Main treatment effect	Reduction of elevated Hb_A1c	48.4	48.9	47.6	49.7	44.7
	Improved well-being	37.5	34.7	35.6	40.4	40.5
	Absence of side effects	43.0	43.6	44.6	43.5	37.2
	No limitations of daily life	41.3	40.6	42.8	40.7	36.0
Effect on body weight	Weight gain	15.7	20.7	15.0	12.6	11.4
	No change	55.8	65.8	55.7	50.1	56.3
	Weight loss	54.9	36.5	53.8	65.0	76.2
Mode of application	Flexible time of application	30.4	29.2	32.2	29.8	28.5
	Application linked to meals	22.6	26.9	21.9	22.2	20.7
Type of product	Original product	36.2	37.3	36.9	33.2	35.0
	Generic product	14.3	15.8	13.9	12.8	13.5

Left side: Factors and factor levels which had to be ranked by the study participants. Right side: The weight of factor levels in the total patient population (n = 827) and in subpopulations of patients with normal body weight (22.6%), mild overweight (40.4%), obesity type I (25.8%) and obesity type II+III (11.2%) is shown. Differences in preferences among patient groups are highlighted.

ISSN: 1477-7525